Arthur Pharma key facts
- Manufacturer of advanced pharmaceuticals intended to create generic and innovative drugs for global healthcare needs.
- Notable investors include Addor Capital, Jiuzhi Capital, Changxing Financial Holding, Ruiying Asset Management, Jiaxing Science and Technology City High-tech Industrial Investment — 9 tracked in total.
- Status: Privately Held (backing).
- ·Watch Arthur Pharma: the Monday email on marks, rounds and moves
Arthur Pharma funding rounds
No funding rounds for Arthur Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Arthur Pharma investors
9 investors are on record for Arthur Pharma, including Addor Capital, Jiuzhi Capital, Changxing Financial Holding and Ruiying Asset Management.
About Arthur Pharma
Manufacturer of advanced pharmaceuticals intended to create generic and innovative drugs for global healthcare needs. The company offers research centers in the United States and China, diverse dosage forms including tablets, capsules, injections, and semi-solids, and international manufacturing collaborations, enabling healthcare providers worldwide to access reliable therapies for critical diseases such as cancer and diabetes.
- Sector
- Healthcare
- HQ
- Jiaxing, China
- Founded
- 2020
- Website
- arthurpharma.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Arthur Pharma doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.